Recruitment

Recruitment Status
Withdrawn
Estimated Enrollment
40

Inclusion Criteria

18-60 year old
Seeking treatment for smoking cessation
Capable of giving informed consent and complying with study procedures
...
18-60 year old
Seeking treatment for smoking cessation
Capable of giving informed consent and complying with study procedures
Smoking at least 15 cigarettes per day
Meet DSM-IV criteria for nicotine dependence

Exclusion Criteria

Unstable medical condition, such as uncontrolled hypertension, angina, and oropharyngeal conditions which may make participation hazardous
Current DSM-IV diagnosis of substance dependence, other than nicotine
Pregnancy, lactation, or failure to use adequate contraception methods in women who are currently having sex with men
...
Unstable medical condition, such as uncontrolled hypertension, angina, and oropharyngeal conditions which may make participation hazardous
Current DSM-IV diagnosis of substance dependence, other than nicotine
Pregnancy, lactation, or failure to use adequate contraception methods in women who are currently having sex with men
Risk for suicide
Lifetime history of DSM-IV diagnosis of schizophrenia, schizoaffective disorder, and bipolar disorder or current diagnosis of major depressive disorder
Use of cannabis or alcohol on more than 20 days in the past 30 days
Currently receiving any treatment for nicotine dependence, including nicotine replacement therapy
Current DSM-IV criteria for any other psychiatric disorder that may, according to the investigator's judgment, require either pharmacological or non- pharmacological intervention over the course of the study

Summary

Conditions
Tobacco Use Disorder
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Parallel Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 60 years
Gender
Both males and females

Description

Cigarette smoking remains the leading cause of preventable death and disease worldwide. The purpose of this trial is to evaluate the effectiveness of electronic cigarettes for smoking cessation compared to a similar nicotine replacement therapy, the nicotine inhaler.

Cigarette smoking remains the leading cause of preventable death and disease worldwide. The purpose of this trial is to evaluate the effectiveness of electronic cigarettes for smoking cessation compared to a similar nicotine replacement therapy, the nicotine inhaler.

Inclusion Criteria

18-60 year old
Seeking treatment for smoking cessation
Capable of giving informed consent and complying with study procedures
...
18-60 year old
Seeking treatment for smoking cessation
Capable of giving informed consent and complying with study procedures
Smoking at least 15 cigarettes per day
Meet DSM-IV criteria for nicotine dependence

Exclusion Criteria

Unstable medical condition, such as uncontrolled hypertension, angina, and oropharyngeal conditions which may make participation hazardous
Current DSM-IV diagnosis of substance dependence, other than nicotine
Pregnancy, lactation, or failure to use adequate contraception methods in women who are currently having sex with men
...
Unstable medical condition, such as uncontrolled hypertension, angina, and oropharyngeal conditions which may make participation hazardous
Current DSM-IV diagnosis of substance dependence, other than nicotine
Pregnancy, lactation, or failure to use adequate contraception methods in women who are currently having sex with men
Risk for suicide
Lifetime history of DSM-IV diagnosis of schizophrenia, schizoaffective disorder, and bipolar disorder or current diagnosis of major depressive disorder
Use of cannabis or alcohol on more than 20 days in the past 30 days
Currently receiving any treatment for nicotine dependence, including nicotine replacement therapy
Current DSM-IV criteria for any other psychiatric disorder that may, according to the investigator's judgment, require either pharmacological or non- pharmacological intervention over the course of the study

Tracking Information

NCT #
NCT02004171
Collaborators
National Institute on Drug Abuse (NIDA)
Investigators
  • Principal Investigator: Barney Vaughan, MD New York State Psychiatric Institute/Columbia University
  • Barney Vaughan, MD New York State Psychiatric Institute/Columbia University
About Us
Innovation
Privacy
Terms
Copyright
Get Well Soon © Copyright 2024